By GREGORY ZELLER //
Good news for a Long Island patient population that can use some: A new slate of leading-edge cardiovascular disease-related procedures has come to Nassau County.
Mineola’s NYU Winthrop Hospital is now offering a range of services led by esteemed cardiothoracic surgeon Nader Moazami, who joined New York City-based NYU Langone Health earlier this year. Also strengthening the collaboration is Alex Reyentovich, medical director of NYU Langone Health’s Heart Transplant and Ventricular Assist Device programs.
The collaboration “provides Long Islanders with direct access to a world-class team,” according to NYU Winthrop, which notes new expertise in advanced heart failure and other emergency cases.
Moazami, formerly the director of heart transplantation and mechanical circulatory support at the Cleveland Clinic, now carries the same title at NYU Langone. The surgeon has performed more than 300 heart transplants and “adds to a highly skilled team already serving NYU Winthrop patients,” the Mineola hospital said in a statement.
At NYU Winthrop, Moazami will head up a wide range of largely pre-surgical services, including evaluations of candidates for implanted heart-assist devices and heart transplants. Actual transplants and implantations will still be performed at NYU Langone Medical Center in Manhattan.
Reyentovich is medical director of NYU Langone Health’s Heart Transplant and Ventricular Assist Device programs. The heart-failure specialist and his team bring extensive experience in Left Ventricular Assist Devices – a common option for patients whose heart can no longer pump enough blood to meet the body’s needs.
Their contributions “further elevate our already strong cardiology services,” noted Kevin Marzo, chief of the Mineola hospital’s Cardiology Division. They also extend NYU Langone Health’s topflight services farther east – an important factor for Nassau and Suffolk heart patients, according to Marzo.
“Patients with advanced heart failure often have reduced mobility, so this new collaboration vastly increases patient access,” the cardiologist said. “Long Islanders need look no further than their own backyard for the finest in heart care.”
While actual surgical procedures will still be performed in the city, the integrated system helps create a “seamless process” for many Long Island patients, according to Moazami, including surgical candidates and those “in need of therapies for end-stage heart failure.”
“Already, we’re seeing an exceptionally strong spirit of collaboration in our efforts, working toward the most successful patient outcomes possible,” Moazami said.